Advertisement

Psychotropic Drugs in Pregnancy

  • Lawrence L. Kerns
  • Gilla P. Davis

Abstract

Pregnancy is frequently complicated by the development or recurrence of a serious mental disorder; neurotic, major affective, and psychotic illnesses have all been observed1–4. When a major mental disorder arises in a pregnant woman and threatens her life, health, or that of the fetus, it should be treated early and aggressively to minimize complications and forestall the advance of the disease. Nonbiologic methods like individual psychotherapy, couples or family therapy, social casework, and hospitalization in a supportive, structured milieu should form the first line of treatment. If the illness persists in spite of nonbiological interventions, and if the risks of the inadequately treated disease outweigh the risks associated with a potentially useful medication, then a trial of that medication is clearly indicated.

Keywords

Bipolar Disorder Antipsychotic Drug Psychotropic Drug Prenatal Exposure Teratogenic Effect 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kumar, R. and Robson, K. (1978). Neurotic disturbance during pregnancy and the puerperium: preliminary report of a prospective survey of 119 primiparae. In: Sandler M. (ed.) Mental Illness in Pregnancy and the Puerperium. ( Oxford: Oxford University Press )Google Scholar
  2. 2.
    Targum, S. D. (1979). Dealing with psychosis during pregnancy. Am. Pharmacol., N.S. 19, 18 - 21Google Scholar
  3. 3.
    Molinski, H. A.: Masked depressions in obstetrics and gynecology. Psychother. Psychosom. 31,283 - 7Google Scholar
  4. 4.
    Cox, J. (1979). Psychiatric morbidity and pregnancy: a controlled study of 263 semi- rural Ugandan women. Br. J. Psychiatry, 134,401 -5PubMedCrossRefGoogle Scholar
  5. 5.
    Forfar, J. O. and Nelson, M. M. (1973). Epidemiology of drugs taken by pregnant women: drugs that may affect the fetus adversely. Clin. Pharmacol. Ther., 14,632 - 42PubMedGoogle Scholar
  6. 6.
    Lewis, P. (1983). Drug usage in pregnancy. In: Lewis, P. (ed.) Clinical Pharmacology in Obstetrics. ( Boston: Wright-PSG )Google Scholar
  7. 7.
    Physician’s Desk Reference: 38th Edition (1984). (Oradell, NJ: Medical Economics Company)Google Scholar
  8. 8.
    Boobis, A. R. and Lewis, P. J. (1983). Pharmacokinetics in pregnancy. In: Lewis, P. (ed.) Clinical Pharmacology in Obstetrics, ( Boston: Wright -PSG )Google Scholar
  9. 9.
    Wood, S. M. and Hytten, F. E. (1981). The fate of drugs in pregnancy. Clin. Obstet. Gynecol., 8, 255 - 9Google Scholar
  10. 10.
    Rayburn, W. F. and Andresen, B. D. (1982). Principles of perinatal pharmacology In Rayburn, W. F. and Zuspan, F. (eds.) Drug Therapy in Obstetrics and Gynecology. (Norwalk, CT: Appleton - Century - Crofts)Google Scholar
  11. 11.
    Lewis, P. J. (1978). The effect of psychotropic drugs in the fetus. In: Sandler, M. (ed.) Mental Illness in Pregnancy and the Puerperium, ( Oxford: Oxford University Press )Google Scholar
  12. 12.
    Werboff, J., Gottlieb, J., Dembicki, E. and Havlena, J. (1961). Postnatal effect of antidepressant drugs administered during gestation. Exp. Neurol., 3: 542 - 55PubMedCrossRefGoogle Scholar
  13. 13.
    Werboff, J. and Kesner, R. (1963). Learning deficits of offspring after administration of tranquillizing drugs to the mothers. Nature, 197, 106PubMedCrossRefGoogle Scholar
  14. 14.
    Lewis, P. D., Patel, A., Bender, G. and Balazs, R. (1977). Do drugs acting on the nervous system affect all proliferation in the developing brain? Lancet, 1, 399 - 401CrossRefGoogle Scholar
  15. 15.
    Hill, H. F. and Engblom, J. (1984). Effects of pre- and postnatal haloperidol administrations to pregnant and nursing rats on brain catecholamine levels in their offspring. Dev. Pharmacol. Ther., 7, 188 - 7PubMedGoogle Scholar
  16. 16.
    Ordy, J. M., Samorajski, T. and Collins, R. L. (1966). Prenatal chlorpromazine effects on liver survival and behavior of mice offspring. J. Pharmacol. Exp. Ther., 151,110- 25PubMedGoogle Scholar
  17. 17.
    Golub, M. and Kornetsky, C. (1980). Seizure susceptibility and avoidance conditioning in adult rats treated prenatally with chlorpromazine. Dev. Psychobiol., 7,79 - 88CrossRefGoogle Scholar
  18. 18.
    Cooper, S. J. (1978). Psychotropic drugs in pregnancy: morphological and psychological adverse effects in offspring. J. Biosoc. Sci., 10, 321 - 34PubMedGoogle Scholar
  19. 19.
    Edlund, M. J. and Craig, T. J. (1984). Antipsychotic drug use and birth defects: an epidemiologic reassessment. Comp. Psychol., 25, 32 - 37CrossRefGoogle Scholar
  20. 20.
    Goldberg, H. L. and DiMascio, A. (1978). Psychotropic drugs in pregnancy. In: Lipton, M. A., DiMascio, A. and Killam, K. F. (eds) Psychopharmacology: A Generation of Progress ( New York: Raven Press )Google Scholar
  21. 21.
    Nurnberg, H. G. and Prudic, J. (1984). Guidelines for treatment of psychosis during pregnancy. Hosp. Comm. Psychol., 35, 67 - 71Google Scholar
  22. 22.
    Hill, R. M. and Stern, L. (1979). Drugs in pregnancy: effects on the fetus and newborn. Curr. Therapeutics, 20,131 -50Google Scholar
  23. 23.
    Van Waes, A. and Van de Velde, E. J. (1969). Safety evaluation of haloperidol in the treatment of hyperemesis gravidarum. J. Clin. Pharmacol, 9, 224Google Scholar
  24. 24.
    Hanson, G. W. and Oakley, G. P. (1975). Haloperidol and limb deformity. J. Am. Med. Assoc., 231, 26CrossRefGoogle Scholar
  25. 25.
    Rawlings, W. J., Ferguson, R. and Maddison, T. G. (1963). Phenmetrazine and trifluoperazine. Med. J. Aust., 1, 370Google Scholar
  26. 26.
    Moriarity, A. J. and Nance, N. R. (1963). Trifluoperazine and pregnancy. Can. Med. Assoc. J., 88, 375 - 6Google Scholar
  27. 27.
    Stone, D., Siskind, V., Heinonen, O. P. et al. (1977). Antenatal exposure to the phenothiazines in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score. Am. J. Obstet. Gynecol., 128, 486 - 8Google Scholar
  28. 28.
    Rumeau-Rouquette, C., Goujard, J. and Huel, G. (1977). Possible teratogenic effects of phenothiazines in human beings. Teratology, 15, 57PubMedCrossRefGoogle Scholar
  29. 29.
    Milkovich, L. and Van den Berg, B. J. (1976). An evaluation of the teratogenicity of certain antinauseant drugs. Am. J. Obstet. Gynecol., 125, 244 - 8PubMedGoogle Scholar
  30. 30.
    Hannah, R. S., Roth, S. H. and Spira, W. (1982). The effects of chlorpromazine and phenobarbital on vasculogenesis in the cerebellar cortex. Act. Neuropathol. (Berl.), 57, 306CrossRefGoogle Scholar
  31. 31.
    Patel, A. J., Barochovsky, O., Borges, S. and Lewis, P. D. (1983). Effects of neurotropic drugs on brain cell replication in vivo and in vitro. Monogr. Neurol. Sci., 9, 99 - 110Google Scholar
  32. 32.
    Hannah, R. S., Roth, S. H. and Spira, A. W. (1982). The effects of chlorpromazine and phenobarbital on cerebellar purkinje cells. Teratology, 26, 21 - 5PubMedCrossRefGoogle Scholar
  33. 33.
    Rosengarten, H. and Friedhoff, A. J. (1979). Enduring changes in dopamine receptor cells of pups from drug administration to pregnant and nursing rats. Science, 203, 1133 - 5PubMedCrossRefGoogle Scholar
  34. 34.
    Robertson, R. T., Majka, J. A., Peter, C P. and Bokelman, D. L. (1980)- Effects of prenatal exposure to chlorpromazine on postnatal development and behavior of rats, Toxicol. Appl. Pharmacol, 53,541 -9PubMedCrossRefGoogle Scholar
  35. 35.
    Hoffeld, D. R., NcNew, J. and Webster, R. L. (1968). Effect of tranquillizing drugs during pregnancy on activity of offspring. Nature, 218, 357 - 8PubMedCrossRefGoogle Scholar
  36. 36.
    Dallemagne, G. and Weiss, B. (1982). Altered adult behavior of mice following postnatal treatment with haloperidol. Pharmacol. Biochem. Behav., 16, 761 -7PubMedCrossRefGoogle Scholar
  37. 37.
    Hill, R. M., Desmond, M. M. and Kay, J. L. (1966). Extrapyramidal dysfunction in an infant of a schizophrenic mother. J. Pediatr., 69, 589PubMedCrossRefGoogle Scholar
  38. 38.
    Desmond, M. M., Rudolph, A. J., Hill, R. M. et al. (1967). Behavioral alterations in infants born to mothers on psychoactive medication during pregnancy. In: Farrel, G. (ed.) Congenital Mental Retardation, ( University of Texas, Austin )Google Scholar
  39. 39.
    Kris, E. B. (1965). Children of mothers maintained on pharmacotherapy during pregnancy and postpartum. Curr. Ther. Res., 7, 785 - 9PubMedGoogle Scholar
  40. 40.
    Tamer, A., McKey, R., Arias, D. et al. (1969). Phenothiazine induced extrapyramidal dysfunction in the neonate. J. Pediatr., 75, 479PubMedCrossRefGoogle Scholar
  41. 41.
    Levy, W. and Wisniewsky, K. (1974). Chlorpromazine causing extrapyramidal dysfunction. N. Y. St. Med. J., 74, 684 - 5Google Scholar
  42. 42.
    O’Connor, M., Johnson, G. M. and Jamis, D. I. (1981). Intrauterine effects of phenothiazines. Med. J. Aust., 1, 416PubMedGoogle Scholar
  43. 43.
    Falterman, L. G. and Richardson, D. J. (1980). Small left colon syndrome associated with maternal ingestion of psychotropic drugs. J. Pediatr., 97,300- 10Google Scholar
  44. 44.
    Nielsen, J., Friedrich, U. and Tsubor, T. (1969). Chromosome abnormalities in patients treated with chlorpromazine, perphenazine, and lysergide. Br. Med. J., 3, 634 - 6PubMedCentralPubMedCrossRefGoogle Scholar
  45. 45.
    Gusdon, J. P. and Herbst, G. (1976). The effect of promethazine hydrochloride on fetal and maternal lymphocytes. Am. J. Obstet. Gynecol., 126, 730- 1Google Scholar
  46. 46.
    Mason, C. G. (1977). Ocular accumulation and toxicity of certain systemically administered drugs. J. Toxicol. Env. Health, 2, 977CrossRefGoogle Scholar
  47. 47.
    Van Petten, G. R. (1975). Fetal cardiovascular effects of maternally administered tricyclic antidepressants, In: Morselli, P. L., Garatini, S. and Sereni, F. (eds). Basic and Therapeutic Aspects of Perinatal Pharmacology, ( New York: Raven Press )Google Scholar
  48. 48.
    Barson, A. J. (1972). Malformed infants. Br. Med. J., 2, 45PubMedCentralPubMedCrossRefGoogle Scholar
  49. 49.
    McBride, W. G. (1972). Limb deformities associated with iminodibenzyl hydrochloride. Med. J. Aust., 1, 492PubMedGoogle Scholar
  50. 50.
    Idanpaan-Heikkila, J. and Saxen, L. (1972). Possible teratogenicity of imipramine/ chloropyramine. Lancet, 2, 282Google Scholar
  51. 51.
    Kuenssberg, E. V. and Knox, J. D. (1972). Imipramine in pregnancy. Br. Med. J., 2, 292PubMedCentralPubMedCrossRefGoogle Scholar
  52. 52.
    Sim, M. (1972). Imipramine and pregnancy. Br. Med. J., 2, 45PubMedCentralPubMedCrossRefGoogle Scholar
  53. 53.
    Crombie, D. L., Pinsent, R. J. and Fleming, D. (1972). Imipramine in Pregnancy. Br. Med. J., 1, 745PubMedCentralPubMedCrossRefGoogle Scholar
  54. 54.
    Scanlon, F. J. (1969). Use of antidepressant drugs during the first trimester. Med. J. Aust., 2, 1077PubMedGoogle Scholar
  55. 55.
    Jason, K. M., Cooper, T. B. and Friedman, E. (1981). Prenatal exposure to imipramine alters early behavioral development and beta adrenergic receptors in rats. J. Pharmacol. Exp. Ther., 217, 461PubMedGoogle Scholar
  56. 56.
    Coyle, I. R. (1975). Changes in developing behavior following prenatal administration of imipramine. Pharmacol. Biochem. Behav., 3, 799 - 807PubMedCrossRefGoogle Scholar
  57. 57.
    Coyle, I. R. and Singer, G. (1975). The interactive effects of prenatal imipramine exposure and postnatal rearing conditions on behavior and histology. Psychopharmacologia (Berl.), 44, 253 - 6CrossRefGoogle Scholar
  58. 58.
    File, S. E. and Tucker, J. C. (1984). Prenatal treatment with clomipramine: Effects on the behavior of male and female adolescent rats. Psychopharmacology, 82,221 - 4PubMedCrossRefGoogle Scholar
  59. 59.
    Dorner, G. (1975). Further evidence of permanent behavioral changes in rats treated neonatally with neurodrugs. Endokrinologie, 68,345 - 8Google Scholar
  60. 60.
    Dorner, G., Heicht, K. and Hinz, G. (1975). Teratopsychogenetic effects apparently produced by nonphysiological neurotransmitter concentrations during brain differentiation. Endokrinologie, 68, 323 - 30Google Scholar
  61. 61.
    Dorner, G., Staudt, J., Wenzel, J. et. al. (1977). Further evidence of teratogenic effects apparently produced by neurotransmitters during brain differentiation. Endokrinologie, 70, 326 - 30PubMedGoogle Scholar
  62. 62.
    Schou, M., Amdisen, A. and Streenstrup, O. (1973). Lithium and pregnancy. II. Hazards to women given lithium during pregnancy and delivery. Br. Med. J., 2, 137PubMedCentralPubMedCrossRefGoogle Scholar
  63. 63.
    Wilbanks, G. D., Bressler, B., Peete, H. C. et al (1970). Toxic effects of lithium carbonate in a mother and newborn infant. J. Am. Med. Assoc., 213, 856CrossRefGoogle Scholar
  64. 64.
    Jefferson, J. W., Greist, J. H. and Ackerman, D. L. (1983). Lithium Encyclopedia for Clincial Practice. ( Washington: American Psychiatric Press )Google Scholar
  65. 65.
    Szabo, K. T. (1970). Teratogenic effect of lithium carbonate in the fetal mouse. Nature, 225, 73 - 5PubMedCrossRefGoogle Scholar
  66. 66.
    Linden, S. and Rich, C. L. (1983). The use of lithium during pregnancy and lactation. J. Clin. Psychiatry, 44, 358 - 61PubMedGoogle Scholar
  67. 67.
    Goldfield, M. D. and Weinstein, M. R. (1971). Lithium in pregnancy: a review with recommendations. Am. J. Psychiatry, 127, 888 - 93PubMedGoogle Scholar
  68. 68.
    Schou, M., Goldfield, M. D., Weinstein, M. R. et al. (1973). Lithium and pregnancy -1. Report from the Register of Lithium Babies. Br. Med. J., 2,135 - 6PubMedCentralPubMedCrossRefGoogle Scholar
  69. 69.
    Weinstein, M. R. and Goldfield, M. D. (1975). Cardiovascular malformations with lithium use during pregnancy. Am. J. Psychol, 132, 529 - 31Google Scholar
  70. 70.
    Hsu, J. M. and Rider, A. A. (1978). Effect of maternal lithium ingestion on biochemical and behavioral characteristics of rat pups. In: Johnson, F. N. and Johnson, S. (eds) Lithium in Medical Practice, ( Baltimore: University Park Press )Google Scholar
  71. 71.
    Morrell, P. etal. (1983). Lithium toxicity in a neonate. Arch. Dis. Child., 58, 539 - 41PubMedCentralPubMedCrossRefGoogle Scholar
  72. 72.
    Schou, M. (1976). What happened later to the lithium babies? Acta Psychiat. Scand., 54, 193 - 7PubMedCrossRefGoogle Scholar
  73. 73.
    Strothers, J. K., Wilson, D. W. and Royston, N. (1973). Lithium toxicity in a newborn. Br. Med. J., 3, 233 - 4CrossRefGoogle Scholar
  74. 74.
    Woody, J. N., London, W. L. and Wilbanks, G. D. (1971). Lithium toxicity in a newborn. Pediatrics, 47, 94 - 6PubMedGoogle Scholar
  75. 75.
    Wilson, N., Forfar, J. C. and Godman, M. J. (1983). Atrial flutter in a newborn resulting from maternal lithium ingestion. Arch. Dis. Child., 58, 538 - 9PubMedCentralPubMedCrossRefGoogle Scholar
  76. 76.
    Arnon, R. G., Marin-Garcia, J. and Peeden, J. N. (1981). Tricuspid valve regurgitation and lithium carbonate toxicity in a newborn infant. Am. J. Dis. Child., 135,941 - 3Google Scholar
  77. 77.
    Karlsson, K., Linstedt, G., Lundberg, P. A. and Selstam, U. (1975). Transplacental lithium poisoning: reversible inhibition of fetal thyroid. Lancet, 1, 1295PubMedCrossRefGoogle Scholar
  78. 78.
    Mizrahi, E. M., Hobbs, J. and Goldsmith, D. (1979). Nephrogenic diabetes insipidus in transplacental lithium intoxication. J. Pediatr., 94, 493 - 5PubMedCrossRefGoogle Scholar

Copyright information

© MTP Press Limited 1986

Authors and Affiliations

  • Lawrence L. Kerns
  • Gilla P. Davis

There are no affiliations available

Personalised recommendations